United States Glucosylceramidase Market Report 2017

December 2017 | 95 pages | ID: UC79DA20FF2EN
QYResearch

Abstracts

In this report, the United States Glucosylceramidase market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Glucosylceramidase in these regions, from 2012 to 2022 (forecast).

United States Glucosylceramidase market competition by top manufacturers/players, with Glucosylceramidase sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Amicus Therapeutics, Inc.
• Bioorganic Research and Services S.A.
• greenovation Biotech GmbH
• JCR Pharmaceuticals Co., Ltd.
• Pharming Group N.V.
• Protalix BioTherapeutics, Inc.
• Shire Plc
• The International Biotechnology Center (IBC) Generium

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• AVRRD-02
• LTI-291
• NCGC-607
• Pcgin
• Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Genetic Disorders
• Gaucher Disease
• Parkinson's Disease
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Glucosylceramidase Market Report 2017

1 GLUCOSYLCERAMIDASE OVERVIEW

1.1 Product Overview and Scope of Glucosylceramidase
1.2 Classification of Glucosylceramidase by Product Category
  1.2.1 United States Glucosylceramidase Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Glucosylceramidase Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 AVRRD-02
  1.2.4 LTI-291
  1.2.5 NCGC-607
  1.2.6 Pcgin
  1.2.7 Others
1.3 United States Glucosylceramidase Market by Application/End Users
  1.3.1 United States Glucosylceramidase Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Genetic Disorders
  1.3.3 Gaucher Disease
  1.3.4 Parkinson's Disease
  1.3.5 Others
1.4 United States Glucosylceramidase Market by Region
  1.4.1 United States Glucosylceramidase Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Glucosylceramidase Status and Prospect (2012-2022)
  1.4.3 Southwest Glucosylceramidase Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Glucosylceramidase Status and Prospect (2012-2022)
  1.4.5 New England Glucosylceramidase Status and Prospect (2012-2022)
  1.4.6 The South Glucosylceramidase Status and Prospect (2012-2022)
  1.4.7 The Midwest Glucosylceramidase Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Glucosylceramidase (2012-2022)
  1.5.1 United States Glucosylceramidase Sales and Growth Rate (2012-2022)
  1.5.2 United States Glucosylceramidase Revenue and Growth Rate (2012-2022)

2 UNITED STATES GLUCOSYLCERAMIDASE MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Glucosylceramidase Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Glucosylceramidase Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Glucosylceramidase Average Price by Players/Suppliers (2012-2017)
2.4 United States Glucosylceramidase Market Competitive Situation and Trends
  2.4.1 United States Glucosylceramidase Market Concentration Rate
  2.4.2 United States Glucosylceramidase Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Glucosylceramidase Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES GLUCOSYLCERAMIDASE SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Glucosylceramidase Sales and Market Share by Region (2012-2017)
3.2 United States Glucosylceramidase Revenue and Market Share by Region (2012-2017)
3.3 United States Glucosylceramidase Price by Region (2012-2017)

4 UNITED STATES GLUCOSYLCERAMIDASE SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Glucosylceramidase Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Glucosylceramidase Revenue and Market Share by Type (2012-2017)
4.3 United States Glucosylceramidase Price by Type (2012-2017)
4.4 United States Glucosylceramidase Sales Growth Rate by Type (2012-2017)

5 UNITED STATES GLUCOSYLCERAMIDASE SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Glucosylceramidase Sales and Market Share by Application (2012-2017)
5.2 United States Glucosylceramidase Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES GLUCOSYLCERAMIDASE PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Amicus Therapeutics, Inc.
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Glucosylceramidase Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Amicus Therapeutics, Inc. Glucosylceramidase Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Bioorganic Research and Services S.A.
  6.2.2 Glucosylceramidase Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Bioorganic Research and Services S.A. Glucosylceramidase Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 greenovation Biotech GmbH
  6.3.2 Glucosylceramidase Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 greenovation Biotech GmbH Glucosylceramidase Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 JCR Pharmaceuticals Co., Ltd.
  6.4.2 Glucosylceramidase Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 JCR Pharmaceuticals Co., Ltd. Glucosylceramidase Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Pharming Group N.V.
  6.5.2 Glucosylceramidase Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Pharming Group N.V. Glucosylceramidase Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Protalix BioTherapeutics, Inc.
  6.6.2 Glucosylceramidase Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Protalix BioTherapeutics, Inc. Glucosylceramidase Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Shire Plc
  6.7.2 Glucosylceramidase Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Shire Plc Glucosylceramidase Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 The International Biotechnology Center (IBC) Generium
  6.8.2 Glucosylceramidase Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 The International Biotechnology Center (IBC) Generium Glucosylceramidase Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview

7 GLUCOSYLCERAMIDASE MANUFACTURING COST ANALYSIS

7.1 Glucosylceramidase Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Glucosylceramidase

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Glucosylceramidase Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Glucosylceramidase Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES GLUCOSYLCERAMIDASE MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Glucosylceramidase Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Glucosylceramidase Sales Volume Forecast by Type (2017-2022)
11.3 United States Glucosylceramidase Sales Volume Forecast by Application (2017-2022)
11.4 United States Glucosylceramidase Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Glucosylceramidase
Figure United States Glucosylceramidase Market Size (K Pcs) by Type (2012-2022)
Figure United States Glucosylceramidase Sales Volume Market Share by Type (Product Category) in 2016
Figure AVRRD-02 Product Picture
Figure LTI-291 Product Picture
Figure NCGC-607 Product Picture
Figure Pcgin Product Picture
Figure Others Product Picture
Figure United States Glucosylceramidase Market Size (K Pcs) by Application (2012-2022)
Figure United States Sales Market Share of Glucosylceramidase by Application in 2016
Figure Genetic Disorders Examples
Table Key Downstream Customer in Genetic Disorders
Figure Gaucher Disease Examples
Table Key Downstream Customer in Gaucher Disease
Figure Parkinson's Disease Examples
Table Key Downstream Customer in Parkinson's Disease
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Glucosylceramidase Market Size (Million USD) by Region (2012-2022)
Figure The West Glucosylceramidase Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Glucosylceramidase Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Glucosylceramidase Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Glucosylceramidase Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Glucosylceramidase Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Glucosylceramidase Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Glucosylceramidase Sales (K Pcs) and Growth Rate (2012-2022)
Figure United States Glucosylceramidase Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Glucosylceramidase Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table United States Glucosylceramidase Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table United States Glucosylceramidase Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Glucosylceramidase Sales Share by Players/Suppliers
Figure 2017 United States Glucosylceramidase Sales Share by Players/Suppliers
Figure United States Glucosylceramidase Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Glucosylceramidase Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Glucosylceramidase Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Glucosylceramidase Revenue Share by Players/Suppliers
Figure 2017 United States Glucosylceramidase Revenue Share by Players/Suppliers
Table United States Market Glucosylceramidase Average Price (USD/Pcs) of Key Players/Suppliers (2012-2017)
Figure United States Market Glucosylceramidase Average Price (USD/Pcs) of Key Players/Suppliers in 2016
Figure United States Glucosylceramidase Market Share of Top 3 Players/Suppliers
Figure United States Glucosylceramidase Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Glucosylceramidase Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Glucosylceramidase Product Category
Table United States Glucosylceramidase Sales (K Pcs) by Region (2012-2017)
Table United States Glucosylceramidase Sales Share by Region (2012-2017)
Figure United States Glucosylceramidase Sales Share by Region (2012-2017)
Figure United States Glucosylceramidase Sales Market Share by Region in 2016
Table United States Glucosylceramidase Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Glucosylceramidase Revenue Share by Region (2012-2017)
Figure United States Glucosylceramidase Revenue Market Share by Region (2012-2017)
Figure United States Glucosylceramidase Revenue Market Share by Region in 2016
Table United States Glucosylceramidase Price (USD/Pcs) by Region (2012-2017)
Table United States Glucosylceramidase Sales (K Pcs) by Type (2012-2017)
Table United States Glucosylceramidase Sales Share by Type (2012-2017)
Figure United States Glucosylceramidase Sales Share by Type (2012-2017)
Figure United States Glucosylceramidase Sales Market Share by Type in 2016
Table United States Glucosylceramidase Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Glucosylceramidase Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Glucosylceramidase by Type (2012-2017)
Figure Revenue Market Share of Glucosylceramidase by Type in 2016
Table United States Glucosylceramidase Price (USD/Pcs) by Types (2012-2017)
Figure United States Glucosylceramidase Sales Growth Rate by Type (2012-2017)
Table United States Glucosylceramidase Sales (K Pcs) by Application (2012-2017)
Table United States Glucosylceramidase Sales Market Share by Application (2012-2017)
Figure United States Glucosylceramidase Sales Market Share by Application (2012-2017)
Figure United States Glucosylceramidase Sales Market Share by Application in 2016
Table United States Glucosylceramidase Sales Growth Rate by Application (2012-2017)
Figure United States Glucosylceramidase Sales Growth Rate by Application (2012-2017)
Table Amicus Therapeutics, Inc. Basic Information List
Table Amicus Therapeutics, Inc. Glucosylceramidase Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Amicus Therapeutics, Inc. Glucosylceramidase Sales Growth Rate (2012-2017)
Figure Amicus Therapeutics, Inc. Glucosylceramidase Sales Market Share in United States (2012-2017)
Figure Amicus Therapeutics, Inc. Glucosylceramidase Revenue Market Share in United States (2012-2017)
Table Bioorganic Research and Services S.A. Basic Information List
Table Bioorganic Research and Services S.A. Glucosylceramidase Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Bioorganic Research and Services S.A. Glucosylceramidase Sales Growth Rate (2012-2017)
Figure Bioorganic Research and Services S.A. Glucosylceramidase Sales Market Share in United States (2012-2017)
Figure Bioorganic Research and Services S.A. Glucosylceramidase Revenue Market Share in United States (2012-2017)
Table greenovation Biotech GmbH Basic Information List
Table greenovation Biotech GmbH Glucosylceramidase Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure greenovation Biotech GmbH Glucosylceramidase Sales Growth Rate (2012-2017)
Figure greenovation Biotech GmbH Glucosylceramidase Sales Market Share in United States (2012-2017)
Figure greenovation Biotech GmbH Glucosylceramidase Revenue Market Share in United States (2012-2017)
Table JCR Pharmaceuticals Co., Ltd. Basic Information List
Table JCR Pharmaceuticals Co., Ltd. Glucosylceramidase Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure JCR Pharmaceuticals Co., Ltd. Glucosylceramidase Sales Growth Rate (2012-2017)
Figure JCR Pharmaceuticals Co., Ltd. Glucosylceramidase Sales Market Share in United States (2012-2017)
Figure JCR Pharmaceuticals Co., Ltd. Glucosylceramidase Revenue Market Share in United States (2012-2017)
Table Pharming Group N.V. Basic Information List
Table Pharming Group N.V. Glucosylceramidase Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Pharming Group N.V. Glucosylceramidase Sales Growth Rate (2012-2017)
Figure Pharming Group N.V. Glucosylceramidase Sales Market Share in United States (2012-2017)
Figure Pharming Group N.V. Glucosylceramidase Revenue Market Share in United States (2012-2017)
Table Protalix BioTherapeutics, Inc. Basic Information List
Table Protalix BioTherapeutics, Inc. Glucosylceramidase Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Protalix BioTherapeutics, Inc. Glucosylceramidase Sales Growth Rate (2012-2017)
Figure Protalix BioTherapeutics, Inc. Glucosylceramidase Sales Market Share in United States (2012-2017)
Figure Protalix BioTherapeutics, Inc. Glucosylceramidase Revenue Market Share in United States (2012-2017)
Table Shire Plc Basic Information List
Table Shire Plc Glucosylceramidase Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Shire Plc Glucosylceramidase Sales Growth Rate (2012-2017)
Figure Shire Plc Glucosylceramidase Sales Market Share in United States (2012-2017)
Figure Shire Plc Glucosylceramidase Revenue Market Share in United States (2012-2017)
Table The International Biotechnology Center (IBC) Generium Basic Information List
Table The International Biotechnology Center (IBC) Generium Glucosylceramidase Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure The International Biotechnology Center (IBC) Generium Glucosylceramidase Sales Growth Rate (2012-2017)
Figure The International Biotechnology Center (IBC) Generium Glucosylceramidase Sales Market Share in United States (2012-2017)
Figure The International Biotechnology Center (IBC) Generium Glucosylceramidase Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Glucosylceramidase
Figure Manufacturing Process Analysis of Glucosylceramidase
Figure Glucosylceramidase Industrial Chain Analysis
Table Raw Materials Sources of Glucosylceramidase Major Players/Suppliers in 2016
Table Major Buyers of Glucosylceramidase
Table Distributors/Traders List
Figure United States Glucosylceramidase Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure United States Glucosylceramidase Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Glucosylceramidase Price (USD/Pcs) Trend Forecast (2017-2022)
Table United States Glucosylceramidase Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Glucosylceramidase Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Glucosylceramidase Sales Volume (K Pcs) Forecast by Type in 2022
Table United States Glucosylceramidase Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Glucosylceramidase Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Glucosylceramidase Sales Volume (K Pcs) Forecast by Application in 2022
Table United States Glucosylceramidase Sales Volume (K Pcs) Forecast by Region (2017-2022)
Table United States Glucosylceramidase Sales Volume Share Forecast by Region (2017-2022)
Figure United States Glucosylceramidase Sales Volume Share Forecast by Region (2017-2022)
Figure United States Glucosylceramidase Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources